Technology
Health
Biotechnology
Ultragenyx Pharmaceutical
$62.109876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$62.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.36 (-0.58%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell RARE and other stocks, options, ETFs, and crypto commission-free!
About RARE
Ultragenyx Pharmaceutical Inc. Common Stock, also called Ultragenyx Pharmaceutical, is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Read More Its product includes Mepsevii and Crysvita. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.
Employees
610
Headquarters
Novato, California
Founded
2010
Market Cap
3.56B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
414.11K
High Today
$63.43
Low Today
$61.87
Open Price
$62.68
Volume
625.75K
52 Week High
$90.98
52 Week Low
$37.44
Collections
Technology
Health
Biotechnology
Pharmaceutical
Biopharmaceutical
2014 IPO
US
North America
Price Paid on Robinhood
4% Higher
Right Now
52 Week Low
$37.44
Average Price Paid
$59.62
52 Week High
$90.98
Analyst Ratings
80%
of 20 ratings
Buy
80%
Hold
20%
Sell
0%
RARE Earnings
-$2.09
-$1.46
-$0.84
-$0.21
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 1, After Hours